{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:34:42Z","timestamp":1784554482479,"version":"3.55.0"},"reference-count":15,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T00:00:00Z","timestamp":1715040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Traditional microbiological detection methods used to detect pulmonary infections in people living with HIV (PLHIV) are usually time-consuming and have low sensitivity, leading to delayed treatment. We aimed to evaluate the diagnostic value of metagenomics next-generation sequencing (mNGS) for microbial diagnosis of suspected pulmonary infections in PLHIV.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We retrospectively analyzed PLHIV who were hospitalized due to suspected pulmonary infections at the sixth people hospital of Zhengzhou from November 1, 2021 to June 30, 2022. Bronchoalveolar lavage fluid (BALF) samples of PLHIV were collected and subjected to routine microbiological examination and mNGS detection. The diagnostic performance of the two methods was compared to evaluate the diagnostic value of mNGS for unknown pathogens.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>This study included a total of 36 PLHIV with suspected pulmonary infections, of which 31 were male. The reporting period of mNGS is significantly shorter than that of CMTs. The mNGS positive rate of BALF samples in PLHIV was 83.33%, which was significantly higher than that of smear and culture (44.4%, P&amp;lt;0.001). In addition, 11 patients showed consistent results between the two methods. Futhermore, mNGS showed excellent performance in identifying multi-infections in PLHIV, and 27 pathogens were detected in the BALF of 30 PLHIV by mNGS, among which 15 PLHIV were found to have multiple microbial infections (at least 3 pathogens). Pneumocystis jirovecii, human herpesvirus type 5, and human herpesvirus type 4 were the most common pathogen types.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>For PLHIV with suspected pulmonary infections, mNGS is capable of rapidly and accurately identifying the pathogen causing the pulmonary infection, which contributes to implement timely and accurate anti-infective treatment.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcimb.2024.1395239","type":"journal-article","created":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T04:30:03Z","timestamp":1715056203000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["The diagnostic value of metagenomics next-generation sequencing in HIV-infected patients with suspected pulmonary infections"],"prefix":"10.3389","volume":"14","author":[{"given":"Mingjie","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haizhen","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningbo","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingxia","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,5,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1378\/chest.119.3.844","article-title":"Prognostic markers of short-term mortality in AIDS-associated Pneumocystis carinii pneumonia","volume":"119","author":"Benfield","year":"2001","journal-title":"Chest"},{"key":"B2","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1152\/physrev.00039.2018","article-title":"Pathogenesis of HIV-related lung disease: immunity, infection, and inflammation","volume":"100","author":"Cribbs","year":"2020","journal-title":"Physiol. Rev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12879-020-05746-5","article-title":"The diagnostic value of metagenomic next\u2043generation sequencing in infectious diseases","volume":"21","author":"Duan","year":"2021","journal-title":"BMC Infect. Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/imr.12823","article-title":"T-cell exhaustion in HIV infection","volume":"292","author":"Fenwick","year":"2019","journal-title":"Immunol. Rev."},{"key":"B5","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1146\/annurev-pathmechdis-012418-012751","article-title":"Clinical metagenomic next-generation sequencing for pathogen detection","volume":"14","author":"Gu","year":"2019","journal-title":"Annu. Rev. Pathol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"103639","DOI":"10.1016\/j.ebiom.2021.103639","article-title":"Metagenomic next-generation sequencing to identify pathogens and cancer in lung biopsy tissue","volume":"73","author":"Guo","year":"2021","journal-title":"EBioMedicine"},{"key":"B7","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/rmv.664","article-title":"CMV in critically ill patients: pathogen or bystander","volume":"20","author":"Limaye","year":"2010","journal-title":"Rev. In Med. Virol."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.962441","article-title":"Clinical performance of metagenomic next-generation sequencing for the rapid diagnosis of talaromycosis in HIV-infected patients","volume":"12","author":"Mao","year":"2022","journal-title":"Front. In Cell. Infection Microbiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1378\/chest.97.5.1072","article-title":"Cytomegalovirus in the bronchoalveolar lavage fluid of patients with AIDS","volume":"97","author":"Miles","year":"1990","journal-title":"Chest"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1132472","article-title":"Clinical features and diagnostic value of metagenomic next -generation sequencing in five cases of non-HIV related Pneumocystis jirovecii pneumonia in children","volume":"13","author":"Niu","year":"2023","journal-title":"Front. In Cell. Infection Microbiol."},{"key":"B11","first-page":"353","article-title":"Cytomegalovirus pneumonia","volume":"14","author":"Salomon","year":"1999","journal-title":"Semin. In Respir. Infections"},{"key":"B12","first-page":"1727","article-title":"Pathogenic microorganism detection in AIDS patients using bronchoalveolar lavage fluid","volume":"13","author":"Shi","year":"2020","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/s12890-019-1022-4","article-title":"Metagenomic next-generation sequencing for mixed pulmonary infection diagnosis","volume":"19","author":"Wang","year":"2019","journal-title":"BMC Pulmonary Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1186\/s12879-017-2492-8","article-title":"Outcomes and prognostic factors of non-HIV patients with pneumocystis jirovecii pneumonia and pulmonary CMV co-infection: A Retrospective Cohort Study","volume":"17","author":"Yu","year":"2017","journal-title":"BMC Infect. Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"101613","DOI":"10.1016\/j.eclinm.2022.101613","article-title":"Incidence and mortality of non-AIDS-defining cancers among people living with HIV: A systematic review and meta-analysis","volume":"52","author":"Yuan","year":"2022","journal-title":"EClinicalMedicine"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2024.1395239\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T04:30:09Z","timestamp":1715056209000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2024.1395239\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,7]]},"references-count":15,"alternative-id":["10.3389\/fcimb.2024.1395239"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2024.1395239","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,7]]},"article-number":"1395239"}}